CITIGROUP INC

Position in VKTX — Viking Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Back to VKTX Full portfolio

Position in VKTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$3,556,458

+$1,141,176 QoQ

Shares Held

109,295

+59.2% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Sep 30, 2025

CallValue

$2,110,284

CallShares

80,300

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. VKTX ranks #48 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

All Filings in VKTX

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,556,458	109,295	+59.2%	Shares	Defined	2026-05-11
2025-12-31	$2,415,282	68,655	-83.4%	Shares	Defined	2026-02-13
2025-09-30	$10,895,766	414,603	+416.3%	Shares	Defined	2025-11-10
2025-09-30	$2,110,284	80,300	-90.7%	Call	Defined	2025-11-10
2025-06-30	$22,898,941	864,111	+258.8%	Shares	Defined	2025-08-11
2025-03-31	$5,816,188	240,836	+34.8%	Shares	Defined	2025-05-12
2024-12-31	$7,188,754	178,647	+38.1%	Shares	Defined	2025-02-12
2024-09-30	$8,188,831	129,345	+739.9%	Shares	Defined	2024-11-12
2024-06-30	$816,354	15,400	-84.3%	Call	Defined	2024-08-12
2024-06-30	$5,215,546	98,388	-54.0%	Shares	Defined	2024-08-12
2024-03-31	$17,553,822	214,071	+137.9%	Shares	Defined	2024-05-10
2023-12-31	$1,674,900	90,000	-49.7%	Call	Defined	2024-02-09
2023-12-31	$3,327,894	178,823	-50.3%	Shares	Defined	2024-02-09
2023-09-30	$3,980,605	359,585	+114.3%	Shares	Defined	2023-12-06
2023-06-30	$2,719,372	167,759	+319.4%	Shares	Defined	2023-08-10
2023-06-30	$648,400	40,000	+654.7%	Call	Defined	2023-08-10
2023-03-31	$88,245	5,300	-99.1%	Call	Defined	2023-05-11
2023-03-31	$9,319,687	559,741	+336.6%	Shares	Defined	2023-05-11
2022-12-31	$1,205,173	128,210	+2261.6%	Shares	Defined	2023-02-09
2022-09-30	$14,766	5,429	+463.8%	Shares	Defined	2022-11-10
2022-06-30	$2,782	963	-81.4%	Shares	Defined	2022-08-10
2022-03-31	$15,567	5,189	-97.2%	Shares	Defined	2022-05-12
2021-12-31	$866,911	188,459	+100.3%	Shares	Defined	2022-02-10
2021-09-30	$590,910	94,094	-67.5%	Shares	Defined	2021-11-10
2021-06-30	$1,732,098	289,165	-33.1%	Shares	Defined	2021-08-10
2021-03-31	$2,735,637	432,512	+2409.4%	Shares	Defined	2021-05-13
2020-12-31	$97,038	17,236	+69.0%	Shares	Defined	2021-02-11
2020-12-31	$57,426	10,200	-84.3%	Put	Defined	2021-02-11
2020-12-31	$364,824	64,800	+50.7%	Call	Defined	2021-02-11
2020-09-30	$250,260	43,000	+334.3%	Call	Defined	2020-11-12
2020-09-30	$57,618	9,900	-21.0%	Put	Defined	2020-11-12
2020-09-30	$72,894	12,525	-79.6%	Shares	Defined	2020-11-12
2020-06-30	$441,973	61,300	-19.5%	Call	Defined	2020-08-12
2020-06-30	$548,723	76,106	+567.6%	Shares	Defined	2020-08-12
2020-06-30	$82,194	11,400	-80.1%	Put	Defined	2020-08-12
2020-03-31	$267,696	57,200	-30.9%	Call	Defined	2020-05-12
2020-03-31	$387,634	82,828	+736.6%	Shares	Defined	2020-05-12
2020-03-31	$46,332	9,900	—	Put	Defined	2020-05-12
No filing history on record for this holder in this stock.